Mothers who experience depression take longer to respond to their children during a back-and-forth conversation.
Symptoms of postpartum depression usually begin to arise three weeks after the birth of a child and are defined by differences in mood and anxiety levels. PPD can last for a year or longer. Baby blues, by contrast, typically last for two weeks.
Researchers discuss how postnatal depression and psychosis can lead some mothers to commit violent acts against or even murder their young children.
Pregnant women who participated in group wellness classes for eight weeks were half as likely to suffer depression eight years later compared to women who did not attend the classes.
Expectant mothers who took a two-hour perinatal course called "Help, Understanding, Guidance (HUG) Your Baby" had a significantly reduced risk of postpartum depression and an increase in parental confidence once their baby arrived.
New insights into the maternal brain shed novel light on the neuroscience of parenting and have implications for developing treatments for treating postpartum depression.
An increase in a woman's symptoms of depression from the preconception to the postpartum period raises the risk of behavioral and emotional problems in her children.
Researchers found significant differences in B cells in women with postpartum depression. B cells are important components of the immune system that help produce antibodies and secrete both pro and anti-inflammatory factors.
During the early stages of the COVID pandemic, one in three new mothers reported experiencing postpartum depression, while 1 in 5 had symptoms of major depression. The risks were higher in mothers who formula-fed their infants, and in those whose children were in neonatal ICU.
Younger mothers, first time moms, and women who give birth to twins are at the highest risk of developing postpartum depression, a new study reports.
Changes in the strength of circadian rhythms, the average amount of activity during nighttime rest, and the amount of fragmented sleep a woman experienced during the later stages of pregnancy or following birth were strongly associated with increased risks of developing postpartum depression and anxiety.
Neurosteroid replacement therapy may provide relief of symptoms for new mothers suffering from postpartum depression.
